China Inherited Ventricular Arrhythmias Registry

Recruiting now

Conditions studied: Ventricular Arrythmia

In brief

This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.

Key facts

Study ID

NCT03880708

Run by

China National Center for Cardiovascular Diseases

People needed

500

Starts

2017-10-24

Expected to finish

2027-10-24

Last updated by the study team

2019-03-26

Who can join

Age: any, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosed as Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) or Catecholaminergic polymorphic ventricular tachycardia(CPVT).

You may not qualify if…

• patients were enrolled by other clinical trials.

Where it is running

• China National Center for Cardiovascular Diseases — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.